217190 — Genesem Income Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeMicro CapContrarian

Annual income statement for Genesem, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41,942	59,727	59,603	56,454	68,738
Cost of Revenue
Gross Profit	11,761	20,636	24,028	19,857	29,026
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	43,051	54,087	51,099	52,891	62,196
Operating Profit	-1,109	5,640	8,504	3,563	6,542
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,128	5,333	8,383	3,114	7,192
Provision for Income Taxes
Net Income After Taxes	-1,059	5,242	12,190	3,596	6,121
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,059	5,243	12,233	3,725	6,084
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,059	5,243	12,233	3,725	6,084
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-119	597	1,396	425	695
Dividends per Share